《半日總結》恆指升337點 科網股領漲 美團及快手彈逾8%
阿思達克 05-11 12:20
市場觀望美國通脹數據，港股先跌後升。恆指低開121點後，在科技股帶動下倒升，半日升337點或1.72%，報19,971點；國指升160點或2.41%，報6,818點；恆生科技指數升181點或4.64%，報4,087點。大市半日成交總額660.33億元，滬、深港通南下交易半日分別淨流入20.44億及27.55億元人民幣。
科技股方面，騰訊(00700.HK)升4.4%報356.2元，阿里巴巴(09988.HK)升1.1%報86.95元，美團(03690.HK)升8.2%報164.2元，小米(01810.HK)升2.4%報11.08元，京東(09618.HK)升3.2%報214.6元，網易(09999.HK)及快手(01024.HK)各升5.5%及8.2%。
嗶哩嗶哩(09626.HK)、眾安在線(06060.HK)及京東健康(06618.HK)各升5.7%至6.5%，金山軟件(03888.HK)及阿里健康(00241.HK)各升7.9%及6.5%。
手機相關股舜宇(02382.HK)、比亞迪電子(00285.HK)及鴻騰(06088.HK)各升5.9%至6.6%，晶片股中芯(00981.HK)及華虹半導體(01347.HK)各升6.6%及4.3%。汽車股急升，大摩引述理想汽車(02015.HK)料本季末供應鏈可回復正常及加價後新訂單回升至疫前水平，理想汽半日股價升11.2%報88.35元。小鵬(09868.HK)、長汽(02333.HK)、比亞迪(01211.HK)及吉利(00175.HK)各升6.5%至7.6%，蔚來(09866.HK)升5.3%。
醫藥股受捧，市場關注中國完成復必泰疫苗II期試驗，復星醫藥(02196.HK)升14.7%報34.4元。藥明生物(02269.HK)及信達生物(01801.HK)各升9.9%及7.3%。
消費股亦上揚，體育用品股特步(01368.HK)、安踏(02020.HK)及李寧(02331.HK)各升5.6%至7.1%。維他奶(00345.HK)炒升7.3%。
新能源及相關股造好，金風科技(02208.HK)及保利協鑫(03800.HK)各升4%及4.8%，新特能源(01799.HK)升5.3%，福萊特玻璃(06865.HK)及信義光能(00968.HK)各升逾6%，福耀玻璃(03606.HK)升8.7%。
金融股方面，匯控(00005.HK)平收報48.45元，港交所(00388.HK)升1%報329元，友邦(01299.HK)跌0.4%報73元。內房股中海外(00688.HK)4月合約物業銷售按年跌36%，股價跌4.2%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
